A new dawn for the management of influenza?
- PMID: 32526194
- PMCID: PMC7279750
- DOI: 10.1016/S1473-3099(20)30459-X
A new dawn for the management of influenza?
Comment on
-
Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial.Lancet Infect Dis. 2020 Oct;20(10):1204-1214. doi: 10.1016/S1473-3099(20)30004-9. Epub 2020 Jun 8. Lancet Infect Dis. 2020. PMID: 32526195 Clinical Trial.
References
-
- Barry JM. Penguin Group; New York City: 2004. The Great Influenza; p. 5. 240.
-
- Centers for Disease Control and Prevention 2017–2018 estimated influenza illnesses, medical visits, hospitalizations, and deaths and estimated influenza illnesses, medical visits, hospitalizations, and deaths averted by vaccination in the United States. 2019. https://www.cdc.gov/flu/about/burden-averted/2017-2018.htm
-
- Molinari N-A M, Ortega-Sanchez IR, Messonier ML. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25:5086–5096. - PubMed
-
- WHO Influenza update—366. 2020. https://www.who.int/influenza/surveillance_monitoring/updates/latest_upd...
-
- Hayden FG, Hay AJ. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr Top Microbiol Immunol. 1992;176:119–130. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
